Blue Cross Blue Shield of Minnesota Medical Policy

 
 

Medical Policy:
IV-123-011
Topic:
Gender Affirming Procedures
Section:
Surgery
Effective Date:
July 3, 2023
Issued Date:
July 3, 2023
Last Revision Date:
April 2023
Annual Review:
April 2023
 
 

Gender affirming medical and surgical treatment (GAMST) is part of the spectrum of care considered for transgender and gender diverse (TGD) individuals. Gender dysphoria refers to the distress that may accompany the incongruence between one’s experienced or expressed gender and one’s sex assigned at birth. TGD individuals may have a gender that blends elements of both genders or doesn’t identify with any gender. The spectrum of gender identities experienced by TGD individuals may include identities such as non-binary, agender, gender fluid, and others. For this policy, the symptoms experienced by all TGD individuals will be referred to as gender dysphoria, recognizing that the spectrum of symptoms may vary from person to person. The therapeutic approach to gender dysphoria, are outlined by the Standards of Care for the Health of Transgender and Gender Diverse People, Version 8 from the World Professional Association for Transgender Health (WPATH). Treatment may involve multiple subspecialties, including but not limited to, primary care, speech and language therapy, endocrinology, dermatology, mental health, physical therapy, and surgical modalities. Gender affirming care interventions and/or GAMSTs consist of several interventions with the type and sequence of interventions differing from person to person. These include, but are not limited to, psychological and social interventions, social transition and/or treatment with hormones and/or surgery to change the genitalia and other sex characteristics.

This policy is designed to address medical guidelines that are appropriate for the majority of individuals with a particular disease, illness, or condition. Each person's unique clinical circumstances may warrant individual consideration, based on review of applicable medical records.

Policy Position Coverage is subject to the specific terms of the member's benefit plan.

I.   Criteria for All Procedures

Criteria are based on the Standards of Care for the Health of Transgender and Gender Diverse People, Version 8, from the World Professional Association for Transgender Health (WPATH).

Treatment of gender dysphoria may be considered MEDICALLY NECESSARY AND APPROPRIATE when ALL of the following diagnostic criteria are met in addition to criteria for specific procedures listed in sections II, III, IV, and V:

  • A comprehensive diagnostic assessment has been completed by a health care professional with the following qualifications:
    • Are licensed by their statutory body and hold, at a minimum, a master’s degree or equivalent training in a clinical field relevant to this role and granted by a nationally accredited statutory institution; and
    • Is experienced in the assessment and treatment of gender dysphoria, incongruence, and diversity; and
    • Has competence in the diagnosis of gender diverse identities and expressions, as well as in diagnosing possible comorbid disorders such as mood disorders, personality disorders, and substance related disorders; and
    • Has the ability to recognize and diagnose co-existing mental health concerns and to distinguish these from gender dysphoria; and
    • Ability to assess capacity to consent for treatment; and
    • Participates in engagement with other health care professionals from different disciplines within the field of transgender health for consultation and referral, as needed.
  • AND
  • Based on the comprehensive evaluation, the individual meets the diagnostic criteria for gender dysphoria in adolescents and adults per the Diagnostic and Statistical Manual of Mental Health Disorders Fifth Edition, text revision (DSM 5-TR).
    • A marked incongruence between one's experienced/expressed gender and assigned gender, of at least 6 months' duration as manifested by at least two of the following:
      • A marked incongruence between one's experienced/expressed gender and primary and/or secondary sex characteristics.
      • A strong desire to be rid of one's primary and/or secondary sex characteristics because of a marked incongruence with one's experienced/expressed gender.
      • A strong desire for the primary and/or secondary sex characteristics of another gender. A strong desire to be another gender.
      • A strong desire to be treated as another gender. 
      • A strong conviction that one has the typical feelings and reactions of another gender.
    • AND
    • The condition is associated with clinically significant distress or impairment in social, occupational, or other important areas of functioning;
  • AND
  • Demonstrates the emotional and cognitive maturity required to provide informed consent for the treatment; AND
  • Other conditions (if any) that may interfere with diagnostic clarity, capacity to consent, and gender-affirming medical treatments have been evaluated and addressed; AND
  • The relationship of the member and healthcare provider spans at least 6 months duration; AND
  • Documentation Requirements:
    • One consultation letter must be provided from a qualified healthcare professional (qualifications noted above). The letter must address ALL of the following:
      • The member's gender identifying characteristics; and
      • Results of the member's psychosocial assessment, including all diagnoses; and 
      • The duration of the health professional's relationship with the member including the type of evaluation and therapy or counseling to date; and
      • An explanation that the criteria for surgery have been met, and a brief description of the clinical rationale for supporting the member's request for surgery; and
      • A statement that the member has been informed that WPATH Standards of Care refer to breast/chest and genital surgical treatments as “irreversible,” and that reversal of breast/chest and genital surgical treatment are not eligible for coverage prior to providing informed consent for this surgery; and
      • A statement that informed consent has been obtained from the member. If the member is a minor informed consent from all legal guardians and assent from the minor has been obtained; and
      • A statement that the healthcare professional is available for coordination of care.
    • If surgical intervention is planned, documentation from the surgeon with recommendations for surgery.

Note: All formats of referral documentation including narrative and assessment templates are acceptable as long as criterion items are included.

II.    Breast Surgery

  • Breast surgery (mastectomy or augmentation) for treatment of gender dysphoria may be considered MEDICALLY NECESSARY AND APPROPRIATE when ALL of the following criteria are met:
    • Criteria in Section I are met; AND
    • Age is ONE of the following:
      • The member is 18 years of age; OR
      • Members < 18 years of age will be considered on a case-by-case basis with evidence of ALL of the following:
        • A multidisciplinary team approach is involved for eligible adolescents; and
        • Adolescent demonstrates emotional and cognitive maturity during the informed consent/assent to treatment process. 

III.  Genital Surgery

  • Genital surgery for treatment of gender dysphoria may be considered MEDICALLY NECESSARY AND APPROPRIATE when ALL of the following criteria are met:
    • One or more of the following procedures:
      • Electrolysis or laser hair removal to treat tissue donor sites for planned genital surgery;
      • Hysterectomy, salpingo-oophorectomy, orchiectomy, metoidioplasty or phalloplasty, urethroplasty, scrotoplasty, testicular prostheses, penectomy, vaginoplasty, labiaplasty, or clitoroplasty.
    • AND
    • Criteria in Section I are met; AND
    • Age 18 years or older; AND
    • The member has completed 12 continuous months of living in the identity that is congruent with their gender identity.

IV.  Reversal of Breast and Genital Surgery

  • Breast and genital surgical procedures are considered irreversible, in accordance with WPATH Standards of Care, which refer to genital and breast/chest surgical treatments as “irreversible” and therefore advise that patients have sufficient time to absorb information fully before providing informed consent for these surgeries. Therefore, reversal of breast and genital surgical procedures are considered NOT MEDICALLY NECESSARY. 

V.   Additional Secondary Sex Characteristic Gender Affirming Medical and Surgical Procedures

  • Non-surgical procedures for the treatment of gender dysphoria may be considered MEDICALLY NECESSARY AND APPROPRIATE to create and maintain gender specific characteristics as part of the overall desired GAMST treatment plan when ALL of the following criteria are met:
    • One or more of the following procedures:
      • Electrolysis or laser treatment for facial hair removal;
      • Voice therapy.
    • AND
    • Criteria in Section I are met;
  • Surgical procedures for the treatment of gender dysphoria may be considered MEDICALLY NECESSARY AND APPROPRIATE to create and maintain gender specific/non-specific characteristics as part of the overall desired GAMST treatment plan when ALL of the following criteria are met:
    • One or more of the following procedures:
      • Voice modification surgery when voice/speech therapy has been ineffective;
      • Reduction thyroid chondroplasty or trachea shaving (reduction of Adam’s apple);
      • Facial surgery;
      • Face lift or liposuction, only when performed in conjunction with facial surgery.
    • AND
      • Criteria in Section I are met; AND
      • Age 18 years or older; AND
    • AND
  • Documentation Requirements: 
    • For voice modification surgery, documentation from the treating speech therapy provider that speech therapy was tried and failed, and that voice modification surgery will provide further benefit.
  • The following procedures do not have criteria specific to gender dysphoria, and criteria for coverage are addressed in separate medical policies:
    • Panniculectomy/Abdominoplasty;
    • Liposuction

VI.   Revision of Previous Surgery
  • Revision of the initial gender affirming surgery may be considered MEDICALLY NECESSARY AND APPROPRIATE for ANY of the following: 
    • Surgical complication (e.g., hematoma, infection, bleeding, fistula, stricture, wound dehiscence); OR 
    • A functional impairment interfering with activities of daily living (e.g., complete vaginal stenosis, urethral stricture or fistula, inability to have penetrative intercourse, difficulty with voiding while standing); OR 
    • Removal and/or replacement of breast, penile, or testicular prostheses when due to complications (e.g., Baker IV contracture). 
  • Revision of a previous gender affirming surgery because of dissatisfaction with appearance is considered COSMETIC.

 


VII.  Cosmetic Procedures
  • The following procedures are considered COSMETIC unless otherwise addressed by member contract benefits:
    • Gluteal augmentation;
    • Pectoral implants;
    • Calf implants.

11950 11951 11952 11954 14000 14001 14041 15734 15738 15750 15757 15758 15769 15771 15772 15773 15774 15819 15820 15821 15822 15823 15824 15825 15826 15828 15829 15830 15832 15833 15834 15835 15836 15837 15838 15839 15847 15876 15877 15878 15879 17380 17999 19316 19318 19325 19340 19342 19350 21120 21121 21122 21123 21125 21127 21137 21138 21139 21172 21175 21179 21180 21208 21209 21210 21270 21899 30400 30410 30420 30430 30435 30450 31599 31899 40799 53410 53430 54125 54400 54401 54405 54406 54408 54410 54411 54415 54416 54417 54520 54660 54690 55175 55180 55970 55980 56620 56625 56800 56805 57110 57291 57292 57335 58150 58180 58260 58262 58275 58290 58291 58541 58542 58543 58544 58550 58552 58553 58554 58570 58571 58572 58573 58661 58720 58940 64856 64892 64896 67900 92507 92508 92524 96158 96159




Coverage

  • Preventive health screening guidelines developed for the general population are appropriate for transgender and gender diverse persons for organ systems that are unlikely to be affected by hormone therapy. 
  • Gender-specific preventive services are also necessary for transgender and gender diverse persons appropriate to their anatomy. Examples include the following: 
    • Routine Pap smears should be performed as recommended if cervical tissue is present 
    • If mastectomy is not performed, mammograms should be performed as recommended. 
    • Transgender and gender diverse persons treated with estrogen should follow the same screening guidelines for breast cancer as those for all women. 
    • Screening for prostate cancer should be performed as recommended for those persons who have retained their prostate. 
  • Preservation of fertility is subject to the member’s contract benefits. This includes but is not limited to procurement, cryopreservation/freezing, storage/banking, and thawing of reproductive tissues, such as oocytes, ovaries, embryos, spermatozoa, and testicular tissue.

Link to Commercial Pre-Authorization Form: https://www.bluecrossmn.com/sites/default/files/DAM/2021-12/BCBSMN-Pre-Auth-Request-fillable-X18509R07.pdf




Denial Statements

No additional statements.



Links





Blue Cross and Blue Shield of Minnesota medical policies apply generally to all Blue Cross and Blue Plus plans and products. Benefit plans vary in coverage and some plans may not provide coverage for certain services addressed in the medical policies. When determining coverage, reference the member’s specific benefit plan, including exclusions and limitations.

Medicaid products may provide different coverage for certain services, which may be addressed in different policies. For Minnesota Health Care Program (MHCP) policies, please consult the MHCP Provider Manual website.

Medicare products may provide different coverage for certain services, which may be addressed in different policies. For Medicare National Coverage Determinations (NCD), Local Coverage Determinations (LCD), and/or Local Coverage Articles, please consult CMS, National Government Services, or CGS websites. 

Note that services with specific coverage criteria may be reviewed retrospectively to determine if criteria are being met. Retrospective denial of claims may result if criteria are not met.

Blue Cross and Blue Shield of Minnesota reserves the right to revise, update and/or add to its medical policies at any time without notice. Codes listed on this policy are included for informational purposes only and are subject to change without notice. Inclusion or exclusion of a code does not constitute or imply member coverage or provider reimbursement. 

These guidelines are the proprietary information of Blue Cross and Blue Shield of Minnesota. Any sale, copying or dissemination of the medical policies is prohibited; however, limited copying of medical policies is permitted for individual use.

Acknowledgements:

CPT® codes copyright American Medical Association® 2023. All rights reserved.

CDT codes copyright American Dental Association® 2023. All rights reserved.